These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Porteous DJ; Dorin JR; McLachlan G; Davidson-Smith H; Davidson H; Stevenson BJ; Carothers AD; Wallace WA; Moralee S; Hoenes C; Kallmeyer G; Michaelis U; Naujoks K; Ho LP; Samways JM; Imrie M; Greening AP; Innes JA Gene Ther; 1997 Mar; 4(3):210-8. PubMed ID: 9135734 [TBL] [Abstract][Full Text] [Related]
5. rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice. Vidović D; Carlon MS; da Cunha MF; Dekkers JF; Hollenhorst MI; Bijvelds MJ; Ramalho AS; Van den Haute C; Ferrante M; Baekelandt V; Janssens HM; De Boeck K; Sermet-Gaudelus I; de Jonge HR; Gijsbers R; Beekman JM; Edelman A; Debyser Z Am J Respir Crit Care Med; 2016 Feb; 193(3):288-98. PubMed ID: 26509335 [TBL] [Abstract][Full Text] [Related]
6. Is gene therapy in cystic fibrosis a realistic expectation? McElvaney NG Curr Opin Pulm Med; 1996 Nov; 2(6):466-71. PubMed ID: 9363187 [TBL] [Abstract][Full Text] [Related]
7. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439 [TBL] [Abstract][Full Text] [Related]
8. Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways. Rose AC; Goddard CA; Colledge WH; Cheng SH; Gill DR; Hyde SC Gene Ther; 2002 Oct; 9(19):1312-20. PubMed ID: 12224014 [TBL] [Abstract][Full Text] [Related]
14. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications. Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for the respiratory manifestations of cystic fibrosis. Korst RJ; McElvaney NG; Chu CS; Rosenfeld MA; Mastrangeli A; Hay J; Brody SL; Eissa NT; Danel C; Jaffe HA Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S75-87. PubMed ID: 7533609 [TBL] [Abstract][Full Text] [Related]
16. Current status of gene therapy for cystic fibrosis pulmonary disease. Kennedy MJ Am J Respir Med; 2002; 1(5):349-60. PubMed ID: 14720037 [TBL] [Abstract][Full Text] [Related]
17. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Flotte TR; Afione SA; Conrad C; McGrath SA; Solow R; Oka H; Zeitlin PL; Guggino WB; Carter BJ Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10613-7. PubMed ID: 7504271 [TBL] [Abstract][Full Text] [Related]